depression

The digital therapeutic company purchased assets from Waypoint Health Innovations and from Örebro University researcher Fredrik Holländare.

The company’s digital therapeutic aimed at treating depression in teens, SparkRx, was launched in October.

The online platform being developed by USQ will help young people manage anxiety and depression.

They will develop and commercialise three novel digital therapeutic products. 

AI algorithms will inform treatment decisions by recognising patterns of data from past treatments.

The company is releasing its research on mapping biomarkers for depression. 

The new analysis of a Pear Therapeutics-based randomized controlled trial came alongside another investigation that spotted early signs of treatment dropout.

The use of cognitive-behavioral therapy interventions, such as Big Health’s Sleepio program, has been found to improve both sleep and mental health in individuals with insomnia and clinically significant depressive symptoms, according to new research published in the Journal of Sleep Research.

The company said its services are accessible to millions of people through partnerships with over 200 employers, health plans and other strategic partners.

The three-year investigation will use iPhones, Apple Watches and Beddit trackers to monitor sleep, physical activity, heart rate and other daily signs.